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Abstract: Bee bread (BB) is a fermented mixture of plant pollen, honey, and bee saliva that worker
bees use as food for larvae, and for young bees to produce royal jelly. In the present study,
five BB samples, collected from Apis mellifera iberiensis hives located in different apiaries near
Bragança, in the northeast region of Portugal, and one BB commercial sample were characterized
by high-performance liquid chromatography coupled to a diode array detector and electrospray
mass spectrometry (HPLC-DAD-ESI/MS) in terms of phenolic compounds, such as flavonoid
glycoside derivatives. Furthermore, the samples were screened, using in vitro assays, against different
human tumor cell lines, MCF-7 (breast adenocarcinoma), NCI-H460 (non-small cell lung cancer),
HeLa (cervical carcinoma) and HepG2 (hepatocellular carcinoma), and also against non-tumor liver
cells (porcine liver cells, PLP2). The main phenolic compounds found were flavonol derivatives,
mainly quercetin, kaempferol, myricetin, isorhamnetin and herbacetrin glycoside derivatives.
Thirty-two compounds were identified in the six BB samples, presenting BB1 and BB3 with the
highest contents (6802 and 6480 µg/g extract, respectively) and the highest number of identified
compounds. Two isorhamnetin glycoside derivatives, isrohamnetin-O-hexosyl-O-rutinoside and
isorhamnetin-O-pentosyl-hexoside, were the most abundant compounds present in BB1; on the
other hand, quercetin-3-O-rhamnoside was the most abundant flavonol in BB3. However, it was
not possible to establish a correlation between the flavonoids and the observed low to moderate
cytotoxicity (ranging from >400 to 68 µg/mL), in which HeLa and NCI-H460 cell lines were the
most susceptible to the inhibition. To the authors’ knowledge, this is the first report characterizing
glycosidic flavonoids in BB samples, contributing to the chemical knowledge of this less explored
bee product.
Keywords: bee bread; Apis mellifera iberiensis; phenolic compounds; HPLC-DAD-ESI/MS; cytotoxicity
1. Introduction
The nutritional requirements of honeybees, Apis mellifera, are met by the collection of pollen,
nectar, and water. Nectar is the primary source of carbohydrates, while pollen provides proteins,
lipids, vitamins and minerals [1]. Bee bread (BB) is a fermented mixture of plant pollen, honey,
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and bee saliva that worker bees use as food for larvae, and for young bees to produce royal jelly.
Pollen collected by bees is mixed with a small amount of honey and saliva, and packed into the
cells of the honeycomb where it undergoes a chemical change to form a product called bee bread [2].
This mixture undergoes different chemical processes due to the action of distinct enzymes from
glandular secretions, microorganisms, moisture and temperature (35–36 ◦C chamber temperature
offspring), allowing the transformation, improvement and preservation of the stored pollen, which is
called bee bread after two weeks of initial storage [3,4].
Despite the role of BB as the main source of protein for the bees, its functional properties have
been correlated, as well as its flavonoid content, with the BB’s floral origin [4]. In particular, BB has
demonstrated in vitro antibacterial [5,6], antioxidant [3], and antitumor [2,7] properties. For the last
activity, ethanolic extracts were screened against tumor cell lines (human glioblastoma cell line U87MG)
and the normal human astroglia cell line SVGp12 (CRL-08621) using in vitro assays [2,7].
The BB composition varies according to the origin of the pollen but is mainly composed of water,
proteins, carbohydrates, lipids, inorganic elements and various other minor components such as
decanoic acid, gamma globulin, nucleic acids, vitamins B and C, pantothenic acid, biopterin, neopterin,
acetylcholine, and reproductive hormones, among others [8].
The quality information available on the literature for bee bread remains limited, with few reports
on the phenolic composition of this mixture. Some phenolic compounds were previously identified in
BB samples from Poland, Russia, Latvia and Georgia [9,10]. Other reports on BB samples from Spain
and Poland mentioned only total phenolics measured by the Folin-Ciocalteu colorimetric assay [2,4]
and did not provide detailed characterization in terms of individual phenolic compounds.
In the present study, five BB samples, collected from Apis mellifera iberiensis hives located in
different apiaries near Bragança, in the northeast region of Portugal, and one sample of commercial BB
were characterized by HPLC-DAD-ESI/MS in terms of their phenolic profile. Furthermore, the samples
were screened against different human tumor cell lines, as well as against non-tumor liver cells.
2. Results and Discussion
2.1. Chromatographic Profile of the BB
The chromatographic profile of BB1 recorded at 370 nm can be observed in Figure 1; the peak
characteristics, tentative identities and quantification of all the samples are presented in Table 1 and the
quantification results are presented in Table 2. The main phenolic compounds found in bee bread were
flavonol derivatives, mainly quercetin, kaempferol, myricetin, isorhamnetin and herbacetrin glycosides.
The phenolic composition of bee bread has hardly been explored, only having been reported by a few
authors [2,9,10], but using different analytical approaches. Tavdidishvili et al. [10] used HPLC-UV-Vis
to study Georgian bee bread samples, reporting the presence of three flavonoids, naringin, rutin
and quercetin. Isidorou et al. [9], using GC-MS, identified four phenolic acids (4-hydroxybenzoic,
p-coumaric, ferulic and caffeic acids) and six flavonoids (chrysin, naringenin, kaempferol, isorhamnetin,
apigenin and quercetin), whereas Markiewicz-Zukowska et al. [2], also using GC-MS, reported the
presence of just two flavonoids, kaempferol and apigenin.
In our samples, up to 32 different flavonoids were detected (Table 1). Myricetin-3-O-glucoside
(peak 7), quercetin-3-O-rutinoside (peak 10), kaempferol-3-O-rutinoside (peak 18), quercetin-3-O-glucoside
(peak 19), isorhamnetin-3-O-rutinoside (peak 25) and isorhamnetin-3-O-glucoside (peak 28) were
positively identified according to their retention, mass and UV-vis characteristics in comparison with
commercial standards (Figure 2). Among them, peaks 10, 18 and 19 were found in all the studied samples,
while compounds 7 (BB3), 25 (BB1) and 28 (BB1, BB3, BB5 and BBC) were only detected in some bee bread
samples (Table 2).
Peak 1 presented a pseudomolecular ion [M−H]− at m/z 625, releasing an MS2 fragment at m/z 317
([M − H − 308]−, loss of a deoxyhexosyl-hexoside moiety), corresponding to myricetin. The presence
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of quercetin, kaempferol and isorhamnetin 3-O-rutinosides may point to peak 1 also a 3-O-rutinoside,
and thus it was tentatively assigned as myricetin-3-O-rutinoside.Molecules 2017, 22, 248 3 of 12 
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Figure 1. Individual phenolic compound profile of BB1 recorded at 370 nm. Peak numbering is the
same as in Tables 1 and 2.
Peaks 2, 4, 8, 9 and 26 were identified as quercetin derivatives owing to the product ion observed at
m/z 301 and UV spectra (λmax around 350–358 nm). Peaks 2 and 9 presented the same pseudomolecular
ion [M − H]− at m/z 771. Peak 2’s MS2 fragments revealed the alternative loss of hexosyl (m/z at 609;
−162 u) and deoxyhexosyl-hexoside (m/z at 463; −308 u) residues, indicating the location of each
residue on different positions of the aglycone. Nevertheless, for peak 9 the observation of only one MS2
fragment suggested that the three sugars were linked together. For both peaks 2 and 9, no information
about t identity of the sugar moi ties and the location n the agl cone could be obtained,
so the compounds were t ntativel id ntified as quercetin-O-hexosyl-O-(deoxyhexosyl-hex side) and
quercetin-O-hexosyl-deoxyhexosyl-hexoside, respectively. Nevertheless, the positive identification
of different rutinosides, including quercetin-3-O-rutinoside, in the analyzed samples may suggest a
rutinose identity for the deoxyhexosyl-hexose residue present in peaks 2 and 9. The mass characteristics
of peak 4 ([M − H]− at m/z 625) indicated that it corresponds to a quercetin derivative bearing
two hexosyl residues. The observation of MS2 fragments at m/z 463 (−162 u) and 301 (−162 u)
also indicated the alternative loss of each of the hexosyl moieties, respectively, pointing to their
location on different positions of the aglycone. Thus, this compound was tentatively identified as
quercetin-O-hexosyl-O-h xoside. Figure 3a exemplifies the fragmentation pattern of these types of
compounds, and gives a tentative identification for peak 4. This compound was th maj rity flavonoid
in the commercial sample and it was present in all the samples, with the exception of BB3 (Table 2).
Peaks 8 ([M−H]− at m/z 595) and 26 ([M−H]− at m/z 447) showed a similar fragmentation pattern
as peak 9, only releasing one fragment at m/z 301, from the respective losses of pentosyl-hexoside (294 u)
and deoxyhexose (146 u) moieties, and thus was tentatively assigned as a quercetin-O-pentosyl-hexoside
and a quercetin-O-deoxyhexoside. This latter compound was detected in all the samples, being the
majority flavonoid found in BB3 and BB5. Although MS analysis does not allow concluding about
the nature and position of the substituting sugar, owing to its relatively high abundance in the
analyzed samples, peak 26 can be speculated to correspond to quercitrin (i.e., quercetin-3-O-rhamnoside),
a widespread flavonoid in plants.
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Table 1. Retention time (Rt), wavelengths of maximum absorption in the visible region (λmax), mass spectral data and identification of phenolic compounds in bee
bread samples.
Peak Rt (min) λmax (nm) Molecular ion [M−H]− (m/z) MS2 (m/z) Identification
1 14.3 358 625 317 (100) Myricetin-3-O-rutinoside
2 14.7 350 771 609 (100), 463 (9), 301 (23) Quercetin-O-hexosyl-O-rutinoside
3 14.9 346 755 593 (100), 447 (21), 285 (34) Kaempferol-O-hexosyl-O-rutinoside
4 15.3 350 625 463 (100), 301 (48) Quercetin-O-hexosyl-O-hexoside
5 16.3 350 785 623 (100), 477 (16), 315 (30) Isorhamnetin-O-hexosyl-O-rutinoside
6 16.3 350 639 315 (18), 300 (21) Methyl herbacetrin-O-dihexoside
7 16.5 354 479 317 (100) Myricetin-3-O-glucoside
8 16.7 358 595 301 (100) Quercetin-O-pentosyl-hexoside
9 16.8 356 771 301 (100) Quercetin-O-hexosyl-rutinoside
10 17.3 358 609 301 (100) Quercetin 3-O-rutinoside
11 17.4 350 785 315 (32), 300 (20) Methyl herbacetrin-O-hexosyl-rutinoside
12 17.7 348 609 285 (100) Kaempferol-O-dihexoside
13 18.2 352 623 315 (36), 300 (22) Methyl herbacetrin-3-O-rutinoside
14 18.4 350 639 315 (29), 300 (14) Methyl herbacetrin-O-dihexoside
15 19.0 350 755 285 (100) Kaempferol-O-hexosyl-rutinoside
16 19.3 356 609 315 (100) Isorhamnetin-O-pentosyl-hexoside
17 19.6 354 785 315 (100) Isorhamnetin-O-hexosyl-rutinoside
18 19.8 348 593 285 (100) Kaempferol-3-O-rutinoside
19 20.3 356 463 301 (100) Quercetin-3-O-glucoside
20 20.9 354 609 315 (100) Isorhamnetin-O-pentosyl-hexoside
21 21.9 356 609 315 (100) Isorhamnetin-O-pentosyl-hexoside
22 22.6 350 635 285 (100) Acetyl kaempferol-O-deoxyhexosyl-hexoside
23 22.7 346 477 315 (50), 300 (33) Methyl herbacetrin-3-O-glucoside
24 23.2 356 477 331 (19), 315 (32) Laricitrin-3-O-rhamnoside
25 23.5 356 623 315 (100) Isorhamnetin-3-O-rutinoside
26 24.2 350 447 301 (100) Quercetin-3-O-rhamnoside
27 24.5 348 563 285 (100) Kaempferol-O-pentosyl-deoxyhexoside
28 25.1 356 477 315 (100) Isorhamnetin-3-O-glucoside
29 26.7 350 489 285 (100) Acetyl kaempferol-O-hexoside
30 28.8 346 431 285 (100) Kaempferol-3-O-rhamnoside
31 29.9 350 461 315 (100) Isorhamnetin-3-O-rhamnoside
32 32.5 356 519 315 (100) Acetyl isorhamnetin-O-hexoside
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Table 2. Quantification of the phenolic compounds (µg/g of extract) present in the bee bread samples.
BB1 BB2 BB3 BB4 BB5 BBC NormalDistribution 1 Homoscedasticity
2 Differences
among Means 3
Myricetin-3-O-rutinoside 41 ± 3c nd 322 ± 7a nd 38 ± 4c 118 ± 4b 0.002 0.719 <0.001
Quercetin-O-hexosyl-O-rutinoside 156 ± 8 nd nd nd nd nd - - -
Kaempferol- O-hexosyl-O-rutinoside 69 ± 1 nd nd nd nd nd - - -
Quercetin-O-hexosyl-O-hexoside 129 ± 5c 211 ± 6b nd 127 ± 4c 74 ± 3d 1580 ± 31a <0.001 0.089 <0.001
Isorhamnetin-O-hexosyl-O-rutinoside 2615 ± 54 nd nd nd nd nd - - -
Methyl herbacetrin-O-dihexoside nd 622 ± 25a 70 ± 3d 460 ± 3b 192 ± 1c nd 0.046 0.084 <0.001
Myricetin-3-O-glucoside nd nd 36 ± 2 nd nd nd - - -
Quercetin-O-pentosyl-hexoside 100 ± 5 nd nd nd nd 139 ± 1 0.023 0.148 <0.001
Quercetin-O-hexosyl-rutinoside nd 314 ± 6b 106 ± 9c 367 ± 1a nd nd 0.006 0.290 <0.001
Quercetin 3-O-rutinoside 158 ± 3c 88 ± 5e 312 ± 5b 105 ± 6d 91 ± 2e 377 ± 7a 0.001 0.688 <0.001
Methyl herbacetrin-O-hexosyl-rutinoside nd nd nd nd 217 ± 1 nd - - -
Kaempferol-O-dihexoside nd 91 ± 6c 246 ± 8b 83 ± 4c 108 ± 1c 1167 ± 30a <0.001 0.094 <0.001
Methyl herbacetrin-3-O-rutinoside 186 ± 25c nd 71 ± 1d 435 ± 5a 225 ± 7b nd 0.037 0.119 <0.001
Methyl herbacetrin-O-dihexoside nd nd 39 ± 3d 164 ± 13b 268 ± 11a 105 ± 5c 0.152 0.424 <0.001
Kaempferol-O-hexosyl-rutinoside 212 ± 10d 3597 ± 69b 403 ± 1c 3755 ± 46a nd 130 ± 2e <0.001 0.095 <0.001
Isorhamnetin-O-pentosyl-hexoside 1448 ± 37 nd nd nd nd nd - - -
Isorhamnetin-O-hexosyl-rutinoside nd 103 ± 1 nd 43 ± 3 nd nd 0.009 0.208 <0.001
Kaempferol-3-O-rutinoside 62 ± 7de 94 ± 21d 355 ± 10c 56 ± 4e 815 ± 16b 1627 ± 32a <0.001 0.300 <0.001
Quercetin-3-O-glucoside 248 ± 5a 52 ± 8e 236 ± 1b 53 ± 3e 177 ± 3c 72 ± 1d 0.001 0.249 <0.001
Isorhamnetin-O-pentosyl-hexoside 94 ± 8 nd nd nd nd nd - - -
Isorhamnetin-O-pentosyl-hexoside 30 ± 2 nd 47 ± 3 nd nd nd 0.081 0.743 <0.001
Acetyl kaempferol-O-deoxyhexosyl-hexoside nd nd 20 ± 1 nd 11 ± 1 nd 0.037 0.639 <0.001
Methyl herbacetrin-3-O-glucoside tr 32 ± 4d 53 ± 6c 224 ± 10a 138 ± 17b nd 0.033 0.383 <0.001
Laricitrin-3-O-rhamnoside nd nd 125 ± 5 nd nd nd - - -
Isorhamnetin-3-O-rutinoside 836 ± 35 nd nd nd nd nd - - -
Quercetin-3-O-rhamnoside tr 280 ± 22c 3029 ± 72a 168 ± 19d 2001 ± 17b 190 ± 7d 0.001 0.236 <0.001
Kaempferol-O-pentosyl-deoxyhexoside 82 ± 6 nd nd nd nd nd - - -
Isorhamnetin-3-O-glucoside 140 ± 1b nd 199 ± 1a nd 118 ± 4c 64 ± 2d 0.103 0.269 <0.001
Acetyl kaempferol-O-hexoside nd nd nd nd nd 22 ± 3 - - -
Kaempferol-3-O-rhamnoside nd nd 141 ± 12 nd 29 ± 10 nd 0.038 0.747 <0.001
Isorhamnetin-3-O-rhamnoside nd 73 ± 10c 670 ± 44a nd 232 ± 14b nd 0.022 0.234 <0.001
Acetyl isorhamnetin-O-hexoside 197 ± 12 nd nd nd nd nd - - -
Total flavonoids 6802 ± 204a 5557 ± 179d 6480 ± 128b 6040 ± 76c 4733 ± 106e 5593 ± 118d 0.417 0.804 <0.001
nd: not detected; tr: traces. 1 Normal distribution of the residuals was evaluated using Shapiro-Wilk test (p > 0.05 indicates normal distribution). 2 Homoscedasticity among bread
formulations was tested by Levene’s test: homoscedasticity, p > 0.05; heteroscedasticity, p < 0.05. 3 p < 0.05 indicates that the mean value of the corresponding phenolic compound of at least
one formulation differs from the others, allowing us to perform multiple comparison tests (Tukey’s HSD for homoscedastic distributions, Tamhane’s T2 for heteroscedastic distributions);
for all phenolic compounds detected only in two bee bread samples, differences among means were compared by Student’s t-test. For each bee bread sample, means within a line with
different letters differ significantly (p < 0.05).
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Peaks 3, 12, 15, 27 and 30 were identified as kaempferol glycosides based on their UV spectra
(λmax around 348 nm) and the production of an MS2 fragment ion at m/z 285. Similarly, peaks 5, 16,
17, 20, 21 and 31 were identified as isorhamnetin (λmax around 356 nm, MS2 fragment at m/z 315)
glycosides. Tentative identities of these compounds were assigned based on their pseudomolecular
ions using similar reasoning as for the quercetin derivatives. Thus, peaks 3 ([M − H]− at m/z 755)
and 5 ([M − H]− at m/z 785) could correspond to kaempferol-O-hexosyl-O-(deoxyhexosyl-hexoside)
and isorhamnetin-O-hexosyl-O-(deoxyhexosyl-hexoside), whereas peaks 15 and 17, with the same
pseudomolecular ions as 3 and 5, could correspond to kaempferol-O-hexosyl-deoxyhexosyl-hexoside
(peak 15) and isorhamnetin-O-hexosyl-deoxyhexosyl-hexoside (peak 17). As assumed for the
quercetin derivatives, the positive identification of kaempferol and isorhamnetin 3-O-rutinoside
allows us to speculate that peaks 3 and 5 correspond to kaempferol-O-hexosyl-O-rutinoside and
isorhamnetin-O-hexosyl-O-rutinoside, respectively. Compound 5 was the majority flavonoid in sample
BB1, and compound 15 in BB2 and BB4 samples. Figure 3b exemplifies the fragmentation pattern
of these types of compounds, and gives a tentative identification for peak 5. Peaks 12 ([M − H]−
at m/z 609), 27 ([M − H]− at m/z 563) and 30 ([M − H]− at m/z 431) could be assumed as a
kaempferol-O-dihexoside, kaempferol-O-pentosyl-deoxyhexoside and kaempferol-O-deoxyhexoside,
respectively. This latter might be supposed to be kaempferol-3-O-rhamnoside, based on the same
considerations as for peak 26.
Peaks 16, 20 and 21, mostly identified in sample BB1, showed the same pseudomolecular
ion ([M − H]− at m/z 609), pointing out that they might correspond to different isorhamnetin-O-
pentosyl-hexoside isomers. Peak 31 ([M − H]− at m/z 461), also bearing −146 u (loss of a
deoxyhexosyl moiety), can be speculated to correspond to an isorhamnetin-O-deoxyhexoside, possibly
isorhamnetin-3-O-rhamnoside.
Peaks 22 ([M − H]− at m/z 635) and 32 ([M − H]− at m/z 519) possessed molecular
weights 42 u higher than peaks 18 and 28, pointing to the existence of an additional acetyl
residue, thus being tentatively identified as acetyl kaempferol-O-deoxyhexosyl-hexoside and acetyl
isorhamnetin-O-hexoside, respectively. Similarly, peak 29 ([M − H]− at m/z 489) was tentatively
identified as acetyl kaempferol-O-hexoside.
Peaks 6, 11, 13, 14 and 23 were tentatively identified as methyl-herbacetin glycosides based on
their UV spectra and the production of two MS2 fragments at m/z 315 and 300. This assignment was
supported by the previous identification of similar compounds in bee pollen samples [11–13]. Compound
identities were assigned based on their pseudomolecular ions, as methyl-herbacetin-O-deoxyhexosyl-
hexoside (peak 13), methyl-herbacetin-O-hexoside (peak 23), methyl-herbacetin-O-hexosyl-deoxyhexosyl-
hexoside (peak 11) and two methyl-herbacetin-O-dihexoside isomers (peaks 6 and 14). Peaks 13 and
23 can be speculated to correspond respectively to methyl-herbacetin-3-O-rutinoside and methyl-
herbacetin-3-O-glucoside, taking into account the presence in the samples of equivalent glycosides
derived from other flavonols. With the exception of peak 11, which was only found in sample BB5,
the rest of the methyl-herbacetin derivatives were detected in most of the analyzed samples (Table 2).
Finally, peak 24 ([M − H]− at m/z 477), only detected in sample BB3, showed a similar
fragmentation pattern as the methyl-herbacetin derivatives, releasing in this case two MS2
fragment ions at m/z 331 and 315, and was tentatively identified as a methylmyricetin derivative,
possibly laricitrin (i.e., 3′-O-methylmyricetin). According to its pseudomolecular ion, it would
be a laricitrin-O-deoxyhexoside, which can also be speculated to correspond to laricitrin-3-O-
rhamnoside owing to the detection of other rhamnosides in the sample (peaks 26 and 30). To the
authors' knowledge, this is the first report on the presence of flavonol glycoside derivatives in bee bread.
2.2. Antitumoral Activity of the BB Samples
The BB samples showed some toxicity against the four human tumor cell lines were used: MCF-7
(breast adenocarcinoma), NCI-H460 (non-small cell lung cancer), HeLa (cervical carcinoma) and
HepG2 (hepatocellular carcinoma). However, at the tested concentrations, the samples inhibited
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less than 50% of the growth of the tumor cells, the results being expressed in terms of GI25 values
(sample concentration providing 25% of growth inhibition) (Table 3). BBC was selective for the HeLa
cell line, while BB3 inhibited the growth of all the tested human tumor cell lines, being the only one
that was able to inhibit HepG2 growth. Besides the mentioned data, BB1 and mostly BB2 were also
active against MCF-7, BB4 and BB5 against NCI-H460, and BB1, BB5 and principally BB4 against HeLa.
It should be highlighted that up to 400 µg/mL, none of the BB samples showed toxicity for normal
cells (non-tumor porcine liver primary cells).
Table 3. Cytotoxic activity (GI25 values, µg/mL) of the bee bread (BB) samples.
Human Tumor Cell Lines Non-Tumor Porcine Liver Cells
MCF-7 NCI-H460 HeLa HepG2 PLP2
BB1 186 ± 6a >400 345 ± 13a >400 >400
BB2 84 ± 3c >400 >400 >400 >400
BB3 164 ± 4b 253 ± 10a 225 ± 12bc 67 ± 1 >400
BB4 >400 85 ± 5b 209 ± 21c >400 >400
BB5 >400 68 ± 8b 276 ± 18b >400 >400
BBC >400 >400 366 ± 7a >400 >400
Ellipticine 0.45 ± 0.02 0.74 ± 0.01 0.55 ± 0.03 1.61 ± 0.07 1.06 ± 0.02
GI25 values: sample concentration providing 25% of growth inhibition in human tumor cell lines or in liver primary
culture PLP2. In each column different letters mean significant statistical differences (p < 0.05).
Despite the reports on the antitumor properties of different phenolic compounds, including
flavonoids [14], it was not possible to establish a positive correlation between the concentration of
flavonoids in each sample and the corresponding cytotoxicity. Therefore, these properties could be
attributed to specific individual flavonoids, synergism/antagonism dynamics in the samples and,
moreover, the presence of other compounds rather than flavonoids.
3. Materials and Methods
3.1. Samples Collection
The samples of BB were collected in 2012 from Apis mellifera iberiensis hives located in different
apiaries near Bragança, in the northeast region of Portugal; specifically located in Bragança (BB1),
Montesinho (BB2), Rio de Onor (BB3), Vinhais (BB4), and Castrelos (BB5). For extraction, the frames
next to the bee brood were removed from the hives, freeze and the wax crushed mechanically to collect
the bee bread. An additional commercial sample (BBC), collected from Apis dorsata on the Himalayan
region, was courtesy of Bee Healthy Farms (Springfield, MO, USA).
Once extracted, the samples were lyophilized (FreeZone 4.5 model 7750031, Labconco, Kansas City,
MO, USA), reduced to a fine dried powder (20 mesh), mixed to obtain homogenous samples and
stored in a desiccator, protected from light, until further analysis.
3.2. Standards and Reagents
HPLC-grade acetonitrile was obtained from Merck KgaA (Darmstadt, Germany). Formic and
acetic acids were purchased from Fisher Scientific (Waltham, MA USA). The phenolic compound
standards (myricetin-3-O-glucoside, quercetin-3-O-rutinoside, kaempferol-3-O-rutinoside, quercetin
3-O-glucoside, isorhamnetin-3-O-rutinoside and isorhamnetin-3-O-glucoside) were from Extrasynthese
(Genay, France). The cell lines HeLa, HEPG2, NCI-H460 and MCF-7 were purchased from Deutshe
Sammlung von Mikroorganismen and Zellkulturen Gmbit (DSMZ, Braunschweig, Germany).
Dulbecco’s modified Eagle’s medium (DMEM), hank’s balanced salt solution (HBSS), fetal bovine
serum (FBS), L-glutamine, trypsin-EDTA, penicillin/streptomycin solution (100 U/mL and 100 mg/mL,
respectively) were purchased from Gibco Invitrogen Life Technologies (Carlsbad, CA, USA). Water was
treated in a Milli-Q water purification system (TGI Pure Water Systems, Greenville, SC, USA).
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3.3. Extracts Preparation
A methanol:water (80:20, v/v) extract was obtained from the lyophilized material. Each sample
(1 g) was extracted twice by stirring (25 ◦C at 150 rpm) with 30 mL of methanol:water (80:20, v/v) for
1 h and subsequently filtered through a Whatman No. 4 paper. The combined methanol:water extracts
were evaporated at 40 ◦C (rotary evaporator Büchi R-210, Flawil, Switzerland) to remove the methanol
and further frozen and lyophilized.
3.4. Characterization of the Extracts by HPLC-DAD-ESI/MS
The phenolic compounds were analysed using a Hewlett-Packard 1100 chromatograph
(Hewlett-Packard 1100, Agilent Technologies, Santa Clara, CA, USA) with a quaternary pump and
a diode array detector (DAD) coupled to an HP Chem Station (rev. A.05.04) data-processing station.
A Waters Spherisorb S3 ODS-2 C18, 3 µm (4.6 mm × 150 mm) column thermostatted at 35 ◦C was
used and 10 µL of each sample was injected. The solvents used were: (A) 0.1% formic acid in water,
(B) acetonitrile. The elution gradient established was 15% B for 5 min, 15% B to 20% B over 5 min,
20%–25% B over 10 min, 25%–35% B over 10 min, 35%–50% B for 10 min, and re-equilibration of the
column, using a flow rate of 0.5 mL/min. Double online detection was carried out in the DAD using
280 nm and 370 nm as preferred wavelengths and in a mass spectrometer (MS) connected to HPLC
system via the DAD cell outlet.
MS detection was performed in an API 3200 Qtrap (Applied Biosystems, Darmstadt, Germany)
equipped with an ESI source and a triple quadrupole-ion trap mass analyser that was controlled
by the Analyst 5.1 software. Zero grade air served as the nebulizer gas (30 psi) and turbo gas for
solvent drying (400 ◦C, 40 psi). Nitrogen served as the curtain (20 psi) and collision gas (medium).
The quadrupoles were set at unit resolution. The ion spray voltage was set at −4500 V in the negative
mode. The MS detector was programmed for recording in two consecutive modes: Enhanced MS
(EMS) and enhanced product ion (EPI) analysis. EMS was employed to show full scan spectra, so as to
obtain an overview of all of the ions in sample. Settings used were: declustering potential (DP) −450 V,
entrance potential (EP) −6 V, collision energy (CE) −10 V. EPI mode was performed in order to obtain
the fragmentation pattern of the parent ion(s) in the previous scan using the following parameters:
DP−50 V, EP−6 V, CE−25 V, and collision energy spread (CES) 0 V. Spectra were recorded in negative
ion mode between m/z 100 and 1000.
The phenolic compounds present in the samples were characterised according to their UV and
mass spectra and retention times compared with standards, when available. For the quantitative
analysis of phenolic compounds, a fiev-level calibration curve was obtained by injection of known
concentrations (2.5–100 µg/mL) of different standards compounds: isorahmetin-3-O-glucoside
(y = 218.26x − 0.98; R2 = 0.999); isorahmetin-3-O-rutinoside (y = 284.12x + 67.055; R2 = 0.999);
kaempferol-3-O-glucoside (y = 288.55x − 4.05; R2 = 1); kaempferol-3-O-rutinoside (y = 182.94x + 96.644;
R2 = 1); quercetin-3-O-glucoside (y = 236.33x + 70.006; R2 = 0.999) and quercetin-3-O-rutinoside
(y = 280.87x + 0.37373; R2 = 1). The results were expressed in µg per g of extract.
3.5. Evaluation of In Vitro Cytotoxic Properties of the Extracts
The BB extracts were dissolved in water at 8 mg/mL and then submitted to further dilutions from
400 to 1.56 µg/mL. Four human tumor cell lines were used: MCF-7 (breast adenocarcinoma), NCI-H460
(non-small cell lung cancer), HeLa (cervical carcinoma) and HepG2 (hepatocellular carcinoma).
Cells were routinely maintained as adherent cell cultures in RPMI-1640 medium containing 10%
heat-inactivated FBS and 2 mM glutamine (MCF-7, NCI-H460 HeLa and HepG2 cells), at 37 ◦C,
in a humidified air incubator containing 5% CO2. Each cell line was plated at an appropriate density
(7.5 × 103 cells/well for MCF-7 and NCI-H460 or 1.0 × 104 cells/well for HeLa and HepG2) in 96-well
plates. Sulforhodamine B assay was performed according to a procedure previously described by the
authors [15].
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For evaluation of the cytotoxicity in non-tumor cells, a cell culture was prepared from a freshly
harvested porcine liver obtained from a local slaughterhouse, according to a procedure established by
the authors [16]; it was designed as PLP2. Cultivation of the cells was continued with direct monitoring
every two to three days using a phase contrast microscope. Before confluence was reached, cells were
subcultured and plated in 96-well plates at a density of 1.0 × 104 cells/well, and commercial in DMEM
medium with 10% FBS, 100 U/mL penicillin and 100 µg/mL streptomycin. Ellipticine was used as
positive control and all the results were expressed in GI25 values (concentration that inhibited 25% of
the net cell growth).
3.6. Statistical Analysis
Data on phenolic compounds quantification were expressed as mean ± standard deviation.
Differences in the phenolic compounds levels among each of the assayed bee bread samples were
analyzed through one-way analysis of variance (ANOVA). The fulfilment of the one-way ANOVA
requirements, specifically the normal distribution of the residuals and the homogeneity of variance,
was tested by means of the Shapiro Wilk’s and the Levene’s tests, respectively. All dependent
variables were compared using Tukey’s honestly significant difference (HSD) or Tamhane’s T2 multiple
comparison tests, when homoscedasticity was verified or not, respectively. For all compounds detected
in only two bee bread samples, statistically significant differences among means were classified
according to t-student test. All statistical tests were performed at a 5% significance level using SPSS
software, version 23.0 (IBM Corp., Armonk, NY, USA).
4. Conclusions
Overall, bee bread is a very recent bee product and at this stage it can be collected and consumed
as a food supplement named “bee bread”. To the authors’ knowledge, this is the first report
characterizing glycosidic flavonoids in bee bread samples, contributing to the chemical knowledge
of this less explored bee product. Thirty-two flavonol glycoside derivatives, such as quercetin,
kaempferol, myricetin, isorhamnetin and herbacetrin derivatives, were identified in the six samples
of bee bread. BB1 and BB3 were the bee bread samples that presented the highest content and the
highest number of identified compounds (19 compounds). Two isorhamnetin glycoside derivatives,
isrohamnetin-O-hexosyl-O-rutinoside and isorhamnetin-O-pentosyl-hexoside, were the most abundant
compounds present in BB1; on the other hand, quercetin-3-O-rhamnoside was the most abundant
flavonol in BB3. BB samples showed moderate antitumor activity; however, none of the BB samples
have shown toxicity for normal cells.
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